 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 2001, 21(21):8495-8504
Dominant-Negative Synthesis Suppression of Voltage-Gated Calcium
Channel Cav2.2 Induced by Truncated Constructs
Ayesha
Raghib,
Federica
Bertaso,
Anthony
Davies,
Karen
M.
Page,
Alon
Meir,
Yuri
Bogdanov, and
Annette C.
Dolphin
Department of Pharmacology, University College London, London
WC1E6BT, United Kingdom
 |
ABSTRACT |
Voltage-gated calcium channel 1 subunits consist of four domains
(I-IV), each with six transmembrane segments. A number of truncated
isoforms have been identified to occur as a result of alternative
splicing or mutation. We have examined the functional consequences for
expression of full-length Cav2.2 ( 1B) of its coexpression with truncated constructs of Cav2.2. Domains
I-II or domains III-IV, when expressed individually, together with the
accessory subunits 1b and 2 -1, did not form functional channels. When they were coexpressed, low-density whole-cell currents and functional channels with properties similar to wild-type channels were observed. However, when domain I-II, domain III-IV, or domain I
alone were coexpressed with full-length Cav2.2, they
markedly suppressed its functional expression, although at the single
channel level, when channels were recorded, there were no differences in their biophysical properties. Furthermore, when it was coexpressed with either domain I-II or domain I, the fluorescence of green fluorescent protein (GFP)-Cav2.2 and expression of
Cav2.2 protein was almost abolished. Suppression does not
involve sequestration of the Cav subunit, because loss
of GFP-Cav2.2 expression also occurred in the absence of
subunit, and the effect of domain I-II or domain I could not be
mimicked by the cytoplasmic I-II loop of Cav2.2. It
requires transmembrane segments, because the isolated
Cav2.2 N terminus did not have any effect. Our results indicate that the mechanism of suppression of Cav2.2 by
truncated constructs containing domain I involves inhibition of channel synthesis, which may represent a role of endogenously expressed truncated Cav isoforms.
Key words:
calcium channel; truncation; expression; suppression; protein synthesis; GFP
 |
INTRODUCTION |
Voltage-gated calcium channels
subserve a number of functions, including neurotransmitter release,
regulation of gene transcription, and muscle contraction (Catterall,
2000 ). They are heteromeric complexes consisting minimally of three
subunits, namely the pore-forming 1 subunit and the accessory and 2- subunits. The 1 subunit is the structural and
functional core of the channel and consists of four homologous domains
(Dom I-IV), linked by intracellular loops and with intracellular N and
C termini. Each domain contains six transmembrane-spanning segments
(S1-S6). To date, 10 1 subunits have been cloned and expressed
(Birnbaumer et al., 1994 ; Perez-Reyes and Schneider, 1994 ; Catterall,
2000 ), termed 1A- 1I and 1S, now renamed
Cav1-3 (Ertel et al., 2000 ).
Mutations in calcium channel 1 subunits can contribute to a
number of pathological states, and some of these mutations involve the
introduction of a premature stop codon. For example, in episodic ataxia
type-2 (EA-2), a number of mutations in the
Cav2.1 subunit predict truncated forms of this
channel (Ophoff et al., 1996 ; Denier et al., 1999 ). Most identified
mutations in EA-2 introduce stop codons at the end of domain II-S6, in
domain III-S1, and in the S1 segments of domains III and IV. The
truncation at S1 of domain III is of particular interest because a 95 kDa protein has been identified that normally copurifies with
Cav2.1 (Scott et al., 1998 ). This protein appears
to contain domains I, II, and part of the II-III loop of
Cav2.1. Thus, it is very similar to the predicted
truncation in EA-2. To date, no naturally occurring two-domain splice
variants of Cav2.1 that would give rise to such a
two-domain protein product have been found. Recently, novel splice
variants of Cav1.2 have been identified,
generated by alternative splicing in the II-III loop, which predict two
truncated forms of Cav1.2, consisting of domains
I and II (Wielowieyski et al., 2001 ). In addition, a splice variant of
Cav2.2 has been identified in humans and rodents
that would introduce a stop codon near the end of the II-III loop
(Mittman, Agnew, 2000 ). The expression of this splice variant would
give rise to a protein consisting of domains I and II of
Cav2.2. Little is known about the
tissue-specificity or developmental regulation of expression of such
splice variants, except that an isoform consisting of the first two
domains of Cav1.1 is the main transcript in
newborn muscle, whereas the four-domain isoform is predominant in adult
muscle (Malouf et al., 1992 ). Furthermore, it has recently been found
that during development of a tunicate tadpole, a truncated calcium
channel with homology to Cav1.1, consisting of
domains III and IV with part of domain II was expressed from a maternal
transcript (Okagaki et al., 2001 ).
In the present study, we have examined the expression, physiological
function, and effects on channel protein levels of truncations of the
N-type calcium channel Cav2.2. Our results
indicate that constructs containing transmembrane domain I suppress the
synthesis of full-length Cav2.2.
 |
MATERIALS AND METHODS |
Materials. The following cDNAs were used: rat 1b
(Tomlinson et al., 1993 ), rabbit Cav2.2 (D14157),
rat 2 -1 (M86621), and green fluorescent protein (GFP) mut3b
(Cormack et al., 1996 ).
Truncated Cav2.2 channel
constructs. Constructs containing different domains of the rabbit
Cav2.2 channel were made using the PCR with
primers incorporating either start or stop codons and restriction
enzyme sites. The following primers were used: N-term (forward): 5'-GCG
ACT AGT ATG GTC CGC TTC GGG GAC 3' and (reverse): 5'-GTA CTC GAG
CTA AGG CCA CTC GGT GAT GCG-3' (introduces a stop
codon at the end of the N terminus); Dom I (reverse): 5'-TTA ACT AGT
TTA CTG TGC CTT CAC CAT GCG-3' (introduces a stop
codon at the end of the I-II loop); Dom I-II (reverse): 5'-CTC GAC TAG
TTA CAT GGT CAC AAT GTA GTG-3' (introduces a stop
codon at the end of the II-III loop); Dom III-IV (forward): 5'-TGG CCA
CTA GTA TGG ACA ACC TTG CCA ATG-3' (introduces a start
codon at the beginning of the II-III loop).
In the GFP-Cav2.2, the stop codon of GFP was removed, and
GFP was fused to the N terminus of Cav2.2 by PCR. The
sequence for the forward primer was 5'-GAT GAA CTA TAC AAA
ATG GTC CGC TTC GG-3'. The sequence in italics indicates
the end of GFP (with the stop codon removed), and the
underlined sequence indicates the beginning of Cav2.2. GFP
was fused to the Dom I-II construct using the same primer. Enhanced
yellow fluorescent protein (EYFP) (Clontech, Cowley, UK) was fused onto
the N terminus of the Dom I construct using the primer, 5'-GAG
CTG TAC AAG TCC GGA ATG GTC CGC TTC GGG-3'. The sequence in
italics indicates the end of EYFP, and the underlined sequence
indicates the beginning of Cav2.2. For the I-II loop construct, the following primers were used:
5'-GGAGAATTCGCTATGGAGCGCGAGAGAGTG-3' (forward with an EcoRI
site and a start codon) and 5'-CTGTGCTCTAGACATGCGCCGGATG-3' (reverse
with an incorporated XbaI site). The resulting fragment was
digested with EcoRI and XbaI enzymes and ligated
in frame with the myc- and His-tags of pcDNA3.1/myc-His(+)A
(Invitrogen, Paisley, UK) vector. The validity of the construct
was further confirmed by Western blot, probed with anti-His
antibodies (Abs) (Santa Cruz Biotechnology, Santa Cruz, CA), after
expression in COS-7 cells. The sequences of all constructs were
verified by automated sequencing.
Yeast two-hybrid screening. Yeast two-hybrid studies were
performed using the Matchmaker Gal4 system (Clontech). The N terminus of Cav2.2 was made by PCR using a forward primer
against the vector and the reverse primer: 5' GAT CTC GAG AGG CCA CTC
GGT GAT GCG 3'. This gave a product with an NcoI site
overlapping the 5' ATG start codon and an XhoI site at the
3' end. The digested PCR product was subcloned into the
NcoI-XhoI sites of pACT2 and the
NcoI-SalI sites of pAS2-1. The constructs
containing the C terminus and the I-II loop were made using the
following primers: C terminus: 5' GTG ACC ATG GAC AAT TTT GAG TAC C 3'
and 5' TAT CGA ATT CTA GCA CCG GCG GTC G 3'; I-II loop: 5' GTA ACC ATG
GCT AAG GAG CGC GAG AG 3' and 5' GTA GGA AAT CTG TGC CTT CAC CAT GC 3'.
These PCR products, as well as the entire calcium channel 1b
subunit, were subcloned into the NcoI-EcoRI
sites of both pACT2 and pAS2-1. Competent yeast cells (Y190 strain)
were cotransformed with both plasmids, and -galactosidase
colony-lift filter assays were performed according to the user manual (Clontech).
Cell culture and transfection. COS-7 cells were cultured as
previously described (Campbell et al., 1995 ) and transfected using the
Geneporter transfection reagent (Qbiogene, Harefield, UK). Cells were
plated onto coverslips 2-3 hr before transfection. The cDNAs (all at 1 µg/ml) for Cav2.2 or truncated domain
constructs (Dom I, I-II, III-IV, N terminus, or I-II loop),
2 -1, 1b, and GFP (when used) were mixed in a ratio of 1.5 (or
3):2:1:0.2. When both Cav2.2 and truncated
construct were both present, the ratios were 1.5:1.5:2:1:0.2. When
particular subunits were not used, the volume was made up with water.
The DNA mixture and Geneporter (6 µg and 30 µl, respectively) were
each diluted in 500 µl of serum-free medium, mixed, and applied to
the cells. After 3.5 hr, 1 ml of medium containing 20% serum was added
to the cells, which were then incubated at 37°C for 3 d,
followed by incubation at 27°C, where stated. Lactacystin (CN
Biosciences, Beeston, UK) was stored at
20OC as a 3 mM
stock solution in dimethylsulfoxide (DMSO) and, when used, was added to
the transfected cells at 30 µM.
Immunocytochemistry and confocal microscopy. COS-7 cells
were washed twice in Tris-buffered saline (TBS; 154 mM NaCl, 20 mM Tris, pH
7.4), then fixed in 4% paraformaldehyde in TBS as described (Brice et
al., 1997 ). The cells were permeabilized in 0.02% Triton X-100 and
incubated with blocking solution [20% (v/v) goat serum, 4% (w/v)
bovine serum albumin (BSA), and 0.1% D,L-lysine
in TBS]. In experiments using mouse monoclonal anti-GFP Ab (Clontech), or anti-myc Ab (9E10; Santa Cruz), they were used at 20 and 0.4 µg/ml, respectively, and the secondary Ab was 10 µg/ml goat
anti-mouse IgG conjugated to Texas Red (Molecular Probes, Eugene, OR).
In some experiments, cells were incubated for 20 min with Texas Red phalloidin (6.6 µM; Molecular Probes). The
nuclear dye 4',6-diamidino-2-phenylindole (DAPI; 300 nM; Molecular Probes) was also used to visualize
the nucleus. Cells were then washed in TBS five times for 5 min each. Coverslips were mounted directly onto a microscope slide with Vectorshield (Vector Laboratories, Burlingame, CA), and the cells were
examined on a laser-scanning confocal microscope (Leica TCS SP; Leica,
Milton Keynes, UK). The optical sections were 0.2 µm, and all images
were scanned sequentially to eliminate cross-talk. For the
immunocytochemistry experiments, n = number of
different transfections performed, with at least two coverslips of
cells analyzed per transfection condition.
Western blotting. COS-7 cells were resuspended in hypotonic
buffer (10 mM Tris, pH 7.4), containing protease
inhibitors (complete EDTA-free; Roche Diagnostics, Lewes, UK) and 2 mM EDTA. Aliquots were taken for assay of total
lysate protein (BCA; Perbio Science, Chester, UK), and the remainder of
each sample was then solubilized in SDS-PAGE sample buffer containing
2% SDS. The samples were sonicated briefly (three times for 5 sec each
on ice) and then centrifuged (10,000 × g, 15 min,
4°C) to remove any insoluble material. Samples (50 µg of total
protein/lane) were separated by SDS-PAGE using 7.5% resolving gels and
then transferred electrophoretically to polyvinylidene fluoride
membranes. The membranes were blocked with 3% BSA for 5 hr at 55°C
and then incubated overnight at 20°C with a 1:1000 dilution of either
anti-GFP monoclonal Ab, or an anti-peptide Ab raised in rabbits against
residues 846-861 within the II-III loop of rabbit brain
Cav2.2 and purified by affinity chromatography
using the immobilized synthetic peptide. Secondary Ab (a 1:1000
dilution of goat anti-mouse IgG or goat anti-rabbit IgG horseradish
peroxidase conjugate, respectively) was added, and the membranes were
incubated for 1 hr. After extensive washing, bound Abs were detected
using enhanced chemiluminescence (Amersham Pharmacia Biotech, Little
Chalfont, UK).
Whole-cell electrophysiology. Whole-cell patch-clamp
recording was performed essentially as previously described (Meir et al., 2000 ), with 10 mM
Ba2+ as charge carrier. Only fluorescent
cells expressing GFP were used for recording. The holding potential was
100 mV, and pulses were delivered every 10 sec. Currents were
measured 10 msec after the onset of the test pulse, and the average
over a 2 msec period was calculated and used for subsequent analysis.
The current density-voltage (I-V) relationships
were fitted with a modified Boltzmann equation as follows:
where I is the current density (in picoamperes per
picofarad), Gmax is the maximum
conductance (in nanosiemans per picofarad), Vrev is the reversal potential,
V50,act is the midpoint voltage for
current activation, and k is the slope factor. Data are
expressed as mean ± SEM of the number of replicates,
n. Steady-state inactivation properties were measured by
applying 10 sec pulse from 120 to +10 mV in 10 mV increments,
followed by a 10 msec repolarization to 100 mV before the 40 msec
test pulse to +20 mV. Steady-state inactivation data were fitted with a
single Boltzmann equation of the form:
where Imax is the maximal
current, V50,inact is the half-maximal
voltage for current inactivation,
kinact is the slope factor, and
A1 and
A2 represent the proportion of
inactivating and noninactivating current, respectively.
Single-channel electrophysiology. Recordings were performed
on GFP-positive cells at 20-24°C. Recording pipettes were pulled from borosilicate tubes (World Precision Instruments, Sarasota, FL),
coated with Sylgard (Sylgard 184, Dow Corning, Wiesbaden, Germany), and
fire-polished. The bath solution, designed to zero the resting membrane
potential (Meir and Dolphin, 1998 ) was composed of (in
mM): 135 K-aspartate, 1 MgCl2, 5 EGTA, and 10 HEPES (titrated with KOH,
pH 7.3), and the patch pipettes were filled with a solution of the
following composition (in mM): 100 BaCl2, 10 TEA-Cl, and 10 HEPES, with 200 nM TTX, titrated with TEA-OH to pH 7.4. Both solutions were adjusted to an osmolarity of 320 mOsmol with sucrose. Data were sampled at 10 kHz and filtered on-line at 2 kHz. (Axopatch 200B and Digidata 1200; Axon Instruments, Foster City, CA). Voltages were not corrected for liquid junction potential (Neher, 1995 ), measured to be 15 mV in these solutions.
Leak subtraction was performed as described (Meir et al., 2000 ). Event
detection was performed using the half-amplitude threshold method. Open
time was determined by a single or double exponential fit to the open
time distributions. Closed times were determined similarly using only
patches with no overlapping openings. The latency to first opening was
measured in 2 msec bins and analyzed as described (Meir et al., 2000 ).
In brief, first latency histograms were accumulated and divided by the
number of episodes, to represent the cumulative probability of a first
latency event (PFL). If necessary
these were corrected for the number of channels in the patch. We
considered the number of detectable simultaneously overlapping openings
as representing the number of channels active in the patch (Meir et
al., 2000 ). To strengthen this assumption we included in the latency
analysis only patches with up to three simultaneously overlapping openings.
 |
RESULTS |
Expression of GFP-Cav2.2 and truncated constructs
The functional expression of Cav2.2 in COS-7
cells was investigated using N terminal GFP-fusion proteins of
Cav2.2 and several truncated forms. We first
examined whether the GFP-tagged Cav2.2, expressed
in combination with the accessory subunits 1b and 2 -1, was
able to reproduce the biophysical properties of wild-type Cav2.2. An example of a whole-cell recording of
IBa from COS-7 cells transfected with
GFP-Cav2.2 cDNA is shown in Figure
1a (top panel), together with the voltage protocol used. The
I-V relationship for the GFP-tagged
Cav2.2 is shown in Figure 1b
(filled circles). The GFP tag on the N terminus did
not interfere with the functionality of the channel, because the
current density at +20 mV was 55.1 ± 8.3 pA/pF for the untagged
Cav2.2 channel (n = 12; data not shown), not significantly different from the
GFP-Cav2.2 channel ( 59.2 ± 17.9 pA/pF;
n = 10). Similarly, there were no differences in other
parameters of the I-V relationship (see legend to Fig. 1).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 1.
Functional expression of GFP-tagged
Cav2.2 and formation of functional channels by coexpression
of constructs consisting of Dom I-II and Dom III-IV. Cells were
transfected with the constructs stated together with 1b and
2 -1 cDNAs. a, IBa
recorded from cells transfected with: GFP-Cav2.2
(top panel); GFP-Dom I-II and Dom III-IV
(middle panel), and Dom I-II and Dom III-IV
(bottom panel). Cells held at 100 mV. Test
potentials 50 to +70 mV (only traces between 20 and +10 mV shown).
Asterisks indicate GFP tag. b, Mean
I-V relationships for GFP-Cav2.2 ( ;
n = 10); GFP-Dom I-II and Dom III-IV ( ;
n = 6), and Dom I-II and Dom III-IV ( ;
n = 8);. IBa at +20 mV
was 59.2 ± 17.9 pA/pF (n = 10) for
GFP-Cav2.2 and 55.1 ± 8.3 pA/pF for untagged
Cav2.2 (n = 12; p = NS; data not shown). The I-V parameters were also
unaltered for both V50,act (+8.8 ± 1.5 mV for Cav2.2 and +3.0 ± 3.0 mV for GFP-Cav2.2; p = NS)
and k (+4.4 ± 0.5 for Cav2.2 and
+3.3 ± 0.5 for GFP-Cav2.2; p = NS). For untagged Dom I-II and Dom III-IV,
IBa at 20 mV was 13.2 ± 4.2 pA/pF,
and the I-V parameters were:
V50,act = +11.5 ± 2.8 mV,
k = +4.8 ± 0.6 (p = NS; compared with Cav2.2). GFP-Dom I-II plus Dom III-IV
gave similar results (IBa was 11.4 ± 3.8 pA/pF) with slight shift of V50,act
(+15.0 ± 2.0 mV; p < 0.05 compared with
GFP-Cav2.2) and an increase in k (+5.4 ± 0.4 mV; p < 0.01). When either Dom I-II or Dom
III-IV were expressed alone, no current was detected ( ;
n = 6). c, Steady-state inactivation
curves for GFP-Cav2.2 ( ) and Dom I-II plus Dom III-IV
( ) together with fits (solid lines).
V50,inact was 38.6 ± 0.9 mV for
GFP-Cav2.2 (n = 5) and 40.1 ± 1.3 mV for Dom I-II plus Dom III-IV (n = 5;
p = NS), whereas kinact
values were +9.8 ± 0.8 and +10.9 ± 1.1, respectively
(p = NS).
|
|
GFP-Dom I-II, containing only the first two domains and the
intracellular II-III loop of Cav2.2, when
expressed with 1b and 2 -1, did not elicit any detectable
currents (Fig. 1b, open circles). The same was true for Dom
III-IV, indicating that the hemichannels are unable to form functional
channels alone. In contrast, coexpression of the two hemichannels
(either with or without a GFP tag on Dom I-II) resulted in the
reproducible expression of small whole-cell currents, with properties
otherwise analogous to the native Cav2.2 (Fig.
1a, middle and bottom panels). In cells
expressing untagged Dom I-II and Dom III-IV, a +20 mV step elicited a
current of 13.2 ± 4.2 pA/pF (n = 8).
Coexpression of the GFP-Dom I-II with Dom III-IV resulted in the
expression of currents with similar amplitude at +20 mV ( 11.4 ± 3.8 pA/pF; n = 7). In addition, the steady-state inactivation properties of the reconstituted channel composed of Dom
I-II and Dom III-IV did not differ from those of
GFP-Cav2.2 (Fig. 1c).
Once the functional integrity of the GFP-tagged channel and
hemichannels was proven, the expression of these fusion proteins was
examined using confocal microscopy. Figure
2a shows the localization of
GFP-Cav2.2. This subunit was expressed
throughout the cell (Fig. 2a, left panel)
(n > 10). The cells were also stained with Texas Red
phalloidin to visualize cortical actin, which delineates the plasma
membrane (Fig. 2a, middle panel). The yellow color in
the merged image (arrow) indicates that
GFP-Cav2.2 and Texas Red phalloidin are
colocalized at the plasma membrane (Fig. 2a, right
panel), in accordance with the electrophysiological
results.

View larger version (41K):
[in this window]
[in a new window]
|
Figure 2.
Expression of GFP-tagged Cav2.2
together with Dom I-II or Dom III-IV. Cells were transfected with:
GFP-Cav2.2 (a),
GFP-Cav2.2 and Dom I-II (b),
GFP-Cav2.2 (c),
GFP-Cav2.2 and Dom I-II (d);
GFP-Dom I-II (e); Cav2.2 and
GFP-Dom I-II (f); and GFP-Cav2.2
and Dom III-IV (g), as depicted in the
diagrams on the left. All cells were
cotransfected with 1b and 2 -1. The left panel
shows GFP fluorescence, the middle panel shows either
Texas Red phalloidin (Phal) staining or
immunolocalization of GFP using anti-GFP Ab, and the right
panel shows either the merged image (colocalization indicated
by yellow) or DAPI staining of the nucleus
(blue), as stated. Arrow in
a indicates colocalization of phalloidin staining and
GFP-Cav2.2 at the plasma membrane.
|
|
Effect of coexpression of two domain constructs on
Cav2.2 localization
Having determined the distribution of full-length
GFP-Cav2.2, we next investigated the effect of
Dom I-II or Dom III-IV on the expression of
GFP-Cav2.2. As shown in Figure 2b,
untagged Dom I-II strongly suppressed the expression of
GFP-Cav2.2 (n = 6). This was
evidenced by the complete absence of observable GFP-positive cells.
This could be attributable to a low level of expression, below the
detection capability of the imaging system. Thus, an anti-GFP Ab was
used to amplify the signal of any expressed
GFP-Cav2.2 within the cells. The anti-GFP Ab was
able to detect GFP-Cav2.2 alone (Fig.
2c) ( n = 4), but no staining was detectable
when GFP-Cav2.2 was coexpressed with Dom I-II
(Fig. 2d, center panel) ( n = 4). In
this case, the presence of viable cells was established by using the
nuclear stain DAPI (Fig. 2d, right panel). These results confirm that Dom I-II greatly reduces the expression of GFP-Cav2.2.
When GFP-Dom I-II was expressed alone, it was detectable at the plasma
membrane and throughout the cell (Fig. 2e, right
panel). The subcellular localization of GFP-Dom I-II was
identical to that of GFP-Cav2.2
(n > 10). Interestingly, in the converse of the
coexpression study described above, the expression of GFP-Dom I-II was
not detectably reduced by the presence of untagged
Cav2.2 (Fig. 2f).
The coexpression of GFP-Dom I-II with Dom III-IV did not alter the
GFP expression or localization of GFP-Dom I-II (results not shown;
n = 6). In contrast, coexpression of
GFP-Cav2.2 with Dom III-IV altered the
expression of GFP-Cav2.2 within individual cells, but did not entirely suppress it (Fig. 2g)
(n = 6). In this case,
GFP-Cav2.2 showed a perinuclear localization and
was not readily detectable throughout the cytoplasm or at the plasma membrane by confocal microscopy (Fig. 2g).
Functional effects of coexpression of two-domain constructs
with Cav2.2
Although immunofluorescence studies indicated that Dom I-II
completely suppressed the expression of
GFP-Cav2.2, it was plausible that small amounts
of GFP-Cav2.2 were still expressed. This was confirmed by whole-cell recording, which showed that there was a marked
reduction in IBa current density in
cells expressing GFP-Cav2.2 together with either
Dom I-II or Dom III-IV (Fig.
3a), although the
I-V parameters were unchanged (Fig. 3b).
IBa at +20 mV was 59.2 ± 17.9 pA/pF for GFP-Cav2.2, and was reduced to
19.2 ± 3.6 pA/pF when GFP-Cav2.2 was
coexpressed with Dom I-II (67% reduction; n = 26;
p < 0.001) and 18.1 ± 6.1 pA/pF with Dom
III-IV (69% reduction; n = 12; p < 0.001). The steady-state inactivation parameters for
Cav2.2 were also unchanged by coexpression with Dom I-II (Fig. 3c). Because of the suppression effect, it
was necessary to coexpress free GFP, to facilitate the identification of successfully transfected cells. This did not alter the amplitude of
control Cav2.2 currents (data not shown). We also
examined whether the effect of Dom I-II was a nonspecific result of
coexpressing another transmembrane protein, but no reduction in
IBa was observed when
Cav2.2 was coexpressed with the 2A-adrenergic
receptor under the same conditions
(IBa = 80.1 ± 24.1 pA/pF at
+20 mV; n = 6). We further assessed whether the
decrease in Cav2.2 current amplitude when it was
coexpressed with Dom I-II could be a result of an alteration of
the ratio between the Cav2.2 and truncated
construct cDNAs transfected. Therefore
IBa was examined in cells transfected with half of the normal amount of
GFP-Cav2.2-pMT2 cDNA (1.5 µg/dish), with the
same amount of accessory subunits. No reduction in current amplitude or
alteration in I-V parameters were detected (data not
shown), indicating that the Cav2.2 cDNA
amount was saturating, consistent with the fact that COS-7 cells are
SV40 transformed, and the vector pMT2 contains the SV40 origin of
replication. We consistently observed that, within the range examined,
reduction of the 1 subunit cDNA level decreased the number of cells
transfected but not the current density.

View larger version (43K):
[in this window]
[in a new window]
|
Figure 3.
Functional expression of GFP-tagged
Cav2.2 together with constructs consisting of Dom I-II or
Dom III-IV. Cells were transfected with the cDNA constructs stated.
a, Example traces for GFP-Cav2.2 with
either Dom I-II (top) or Dom III-IV
(bottom). Asterisks indicate GFP tag.
Traces recorded between 20 and +10 mV are shown. b,
I-V relationships for expression of
GFP-Cav2.2 alone ( ) or with Dom I-II ( ) or Dom
III-IV ( ). IBa at +20 mV was 19.2 ± 3.6 pA/pF for GFP-Cav2.2 plus Dom I-II
(n = 26; p < 0.001; compared
with control) and 18.1 ± 6.1 pA/pF for GFP-Cav2.2
plus Dom III-IV (n = 12; p < 0.001). The respective V50,act = +5.2 ± 0.3 mV and + 7.7 ± 0.8 mV. Controls ( ;
n = 10) are the same as for Figure 1 because the
experiments were all performed in parallel. c,
Steady-state inactivation for GFP-Cav2.2 plus Dom I-II.
V50,inact = 37.8 ± 0.8 mV;
kinact = +9.2 ± 0.7;
n = 6; p = NS compared with
GFP-Cav2.2 (Fig. 1). d, Effect of
transfection of different amounts (the standard amount, 1 µg, ; or
1.7 µg/dish, ) of 1b cDNA on IBa for
GFP-Cav2.2 plus Dom I-II. When using 1.7 µg 1b cDNA,
IBa was 19.4 ± 10.7 at +20 mV, and
V50,act was +10.3 ± 0.3 mV,
(n = 8). e, I-V
relationships for Cav2.2 alone ( ; n = 9) or plus myc-tagged I-II loop ( ; n = 11).
For the controls, IBa at +20 mV was
53.5 ± 8.5 pA/pF, and V50,act was
+6.2 ± 1.5 mV. For cells coexpressing the I-II loop,
IBa at +20 mV was 50.3 ± 11.4 pA/pF,
and V50,act was +5.1 ± 1.4 mV.
f, Steady-state inactivation of
IBa in cells coexpressing
GFP-Cav2.2 and I-II loop;
V50,inact = 42.3 ± 1.5 mV;
kinact = +6.9 ± 0.7;
n = 5; p = NS compared with
GFP-Cav2.2. g, Cells transfected with
GFP-Cav2.2 and myc-tagged I-II loop and cotransfected with
1b and 2 -1. GFP, GFP fluorescence;
myc, immunolocalization of myc-I-II loop using anti-myc
Ab; DAPI, DAPI staining of the nucleus; and
merge, merged images. h, Cells
transfected with GFP-Cav2.2 and Dom I-II, in the absence
of 2 -1 or 1b. GFP, Lack of GFP fluorescence;
Phal, Texas Red phalloidin staining;
DAPI, DAPI staining of the nuclei; merge,
merged images.
|
|
To address the mechanism of suppression, we examined whether the
suppressive effect of Dom I-II or Dom III-IV on
Cav2.2 currents could be reduced by coexpression
of both hemichannels together with Cav2.2, a
result that might be predicted because our initial studies showed that
Dom I-II and Dom III-IV were able to interact together to form
functional channels. A protective effect was confirmed, because the
IBa current density at +20 mV in cells expressing GFP-Cav2.2 together with both Dom
I-II and Dom III-IV was 44.4 ± 11.9 pA/pF (n = 9), a nonsignificant 17% reduction (p = 0.54), compared with 53.5 ± 8.1 pA/pF 1 (n = 9) for
control GFP-Cav2.2 currents (same controls as in Fig. 3e, because experiments performed in parallel).
We next examined whether the mechanism of suppression involved an
accelerated degradation of Cav2.2, by examining
the effect of the 26 S proteasome inhibitor lactacystin. When incubated
with cells, at 30 µM, either for the entire period
between transfection and visualization of
GFP-Cav2.2, or for the final 16 hr, lactacystin did not increase GFP fluorescence of GFP-Cav2.2
coexpressed with Dom I-II (compared with controls receiving the same
amount of solvent, n = 6, results not shown).
Is the suppression of expression of GFP-Cav2.2 caused
by sequestration of subunits by the truncated constructs?
The Cav subunits have been shown to act
as chaperone proteins for the calcium channel 1 subunits, enhancing
their translocation from the endoplasmic reticulum to the plasma
membrane (Bichet et al., 2000 ). One possible explanation for the
suppression of Cav2.2 currents is that Dom I-II
acts to sequester free 1b via its I-II loop, and therefore limits
the amount available for chaperoning GFP-Cav2.2
to the membrane. To test this hypothesis, cells were transfected with
increased 1b cDNA, but this did not enhance Cav2.2 IBa
recorded in the presence of Dom I-II (Fig. 3d)
(IBa current density at +20 mV was
19.4 ± 10.7 pA/pF; n = 8). To examine further
whether the effect of Dom I-II on GFP-Cav2.2
was attributable to scavenging of 1b by the I-II loop within Dom
I-II, we also coexpressed GFP-Cav2.2 with a
construct of the Cav2.2 I-II loop, which we have
shown to be capable of binding 1b (Bell et al., 2001 ). No inhibitory
effect was observed (Fig. 3e); the
IBa current density at +20 mV in cells
expressing GFP-Cav2.2 together with the free
I-II loop was 50.3 ± 11.4 pA/pF (n = 11), a
nonsignificant 5% reduction, compared with 53.5 ± 8.1 pA/pF
(n = 9) for GFP-Cav2.2 currents
recorded in parallel, from the same transfections. The steady-state
inactivation parameters for GFP-Cav2.2 were also unchanged by coexpression with Dom I-II (Fig. 3f).
In agreement with this, we saw no reduction of
GFP-Cav2.2 fluorescence when it was coexpressed
with the I-II loop, either in the presence or absence of coexpressed
1b (Fig. 3g) (data not shown; n = 2). Furthermore, omission of both coexpressed accessory subunits ( 1b and
2 -1) did not affect the ability of Dom I-II to suppress expression of GFP-Cav2.2, as determined by its
fluorescence (Fig. 3h) (n = 6). Because
there is very low functional expression of Cav2.2
channels in the absence of these accessory subunits (Meir et al.,
2000 ), it was not possible to perform the corresponding electrophysiological experiments.
In yeast two-hybrid experiments, we observed no interaction of 1b
with the intracellular N terminus or the C terminus of Cav2.2 (n = 3). In every
experiment, an interaction of 1b with a I-II loop construct was
obtained as a positive control (results not shown). This rules out
1b subunit scavenging as a mechanism of action of Dom III-IV, which
contains the C terminus, but not the I-II loop.
Single channel properties of two domain constructs coexpressed
together or with Cav2.2
These experiments were performed to determine whether the small
whole-cell currents obtained either when Dom I-II was coexpressed with
Dom III-IV or when Dom I-II was coexpressed with
Cav2.2 were caused by altered properties of the
channels formed. Single channels were recorded in the cell-attached
mode of the patch clamp technique. The recordings were made from COS-7
cells transfected with GFP-Cav2.2 alone (Fig.
4a), Dom I-II together with
Dom III-IV (Fig. 4b), or GFP-Cav2.2
with Dom I-II (Fig. 4c). In all cases we could detect single channels with a similar mean conductance (Fig. 4d),
mean open time (Fig. 4e), mean closed time (Fig.
4f), and latency to first opening (Fig.
4g; shown at +30 mV). These values are very similar to those
obtained from wild-type Cav2.2 (not tagged with GFP) (Meir et al., 2000 ).

View larger version (41K):
[in this window]
[in a new window]
|
Figure 4.
Properties of single channels formed by
Cav2.2 compared with coexpression of Dom I-II and Dom
III-IV, and coexpression of Cav2.2 with Dom I-II.
Recordings were obtained from cell-attached patches from cells
transfected with the stated 1 subunit or truncated constructs,
together with 2 -1 and 1b. a, Single channel
activity of GFP-Cav2.2. Top, Voltage
protocol: holding potential of 100 mV, test potential to the
indicated value for 100 msec. Steps were delivered every 5 sec. Five
representative patch current traces (in a patch with no overlapping
openings), for the voltage indicated above each column. The zero
current line that runs through the traces, represents the closed state,
and openings are downward deflections. Calibration: 1 pA, 50 msec
(applies to all the voltages). b, Single-channel
activity (in a patch with no overlapping openings) arising from
GFP-Dom I-II coexpressed with Dom III-IV (format as in
a). c, Single-channel activity from a
cell transfected with GFP-Cav2.2 and Dom I-II (in a patch
with no overlapping openings, format as in a).
d-g, The symbols used represent the transfection
conditions described in a ( ;
GFP-Cav2.2), b ( ; GFP-Dom I-II and Dom
III-IV), and c ( ; GFP-Cav2.2 and Dom
I-II). d, Unitary I-V relationships for
the three conditions ( ; n= 10), ( ;
n = 5), and ( ; n = 11).
These were fit by linear regression (the lines here are the average fit
in each condition). The single channel conductance was 12.6 ± 1.0, 11.6 ± 1.2, and 13.8 ± 1.0 pS for the three
conditions, respectively. e, Voltage dependence of mean
channel open times (see Materials and Methods) for the three conditions
( ; n = 8), ( ; n = 5), and
( ; n = 11). f, Voltage dependence
of mean channel closed times for the three conditions ( ;
n = 2), ( ; n = 1), and ( ;
n = 5). g, Latency to first opening
(see Materials and Methods) in response to +30 mV test pulse for the
three conditions ( ; n = 4), ( ;
n = 5), and ( ; n = 4).
|
|
Effect of coexpression of Dom I or the cytoplasmic N terminus on
Cav2.2 expression
We next investigated the minimal domain required for suppression
of Cav2.2 expression. To this end,
GFP-Cav2.2 was coexpressed with either Dom I or
the cytoplasmic N terminus of Cav2.2. The Dom I
construct consisted of the intracellular N terminus, domain I, and the
intracellular I-II loop. Immunofluorescence studies using YFP-Dom I
confirmed its expression throughout COS-7 cells (results not shown). In
a similar manner to Dom I-II, untagged Dom I also appeared to abolish
the expression of GFP-Cav2.2, as assessed by
confocal microscopy (Fig. 5a)
(n = 4). These results were confirmed by using the
anti-GFP Ab, which did not reveal any GFP-Cav2.2
(Fig. 5b) (n = 4). Again, this suppression
was not affected by the absence of accessory subunits (results not shown; n = 4). In contrast, the N terminus of
Cav2.2 did not have any effect on the expression
of GFP-Cav2.2 or on its subcellular localization
(Fig. 5c) (n = 4).
GFP-Cav2.2 was localized at the plasma membrane
(colocalized with phalloidin) and throughout the cytoplasm. In
confirmation of these results, IBa
recorded from cells expressing GFP-Cav2.2 and
Dom I was dramatically reduced, compared with controls (Fig.
5d). IBa at +20 mV was
5.2 ± 1.9 pA/pF (88.4% reduction compared with control;
n = 8). In contrast, the I-V parameters for
cells expressing GFP-Cav2.2 together with the N
terminus did not show any decrease in current amplitude or effect on
activation (Fig. 5d). The steady-state inactivation parameters were also identical to those of
GFP-Cav2.2 (Fig. 5e). This is in
agreement with the lack of interaction observed between the 1b
subunit and the N terminus of Cav2.2 in the yeast
two-hybrid assay.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 5.
Effect of coexpression of Dom I or the
intracellular N terminus of Cav2.2 on Cav2.2
expression and function. All cells were transfected with the constructs
stated and 1b and 2 -1 accessory subunit cDNAs. a,
b, GFP-Cav2.2 and Dom I; c,
GFP-Cav2.2 and the N terminus of Cav2.2.
Left panel shows GFP fluorescence or immunolocalization
of GFP using anti-GFP Ab; middle panel shows either
Texas Red phalloidin or DAPI, and right panel shows the
merged image, as stated. d, I-V
relationships for GFP-Cav2.2 alone ( ,
n = 7; IBa = 44.8 ± 8.9 pA/pF at +20 mV;
V50,act = +6.4 ± 2.1 mV);
GFP-Cav2.2 plus N terminus ( , n = 11; IBa = 44.9 ± 8.6 pA/pF at
+20 mV; V50,act = +8.9 ± 1.8 mV;
p = NS) or GFP-Cav2.2 plus Dom I ( ,
n = 8; IBa = 5.2 ± 1.9 pA/pF at +20 mV;
V50,act = +14.7 ± 1.5 mV; both
p < 0.001 compared with control).
e, Steady-state inactivation curve (fitted with a
Boltzmann function, solid line) for
GFP-Cav2.2 plus N terminus ( ;
V50,inact = 42.0 ± 0.7 mV;
kinact = 7.9 ± 0.7;
n = 5). Data are superimposed on the Boltzmann fit
for the steady-state inactivation curve for GFP-Cav2.2
from Figure 1 for comparison (dotted line).
|
|
Effect of coexpression of truncated constructs on the
Cav2.2 protein level
The GFP-Cav2.2 expressed alone was
detectable by Western blotting using either an anti-GFP Ab or an Ab
against the II-III loop of Cav2.2 (band at ~250
kDa) (Fig. 6a,b, lane 1). A
minor band at 100 kDa was also observed with both Abs, which might
therefore represent an N terminal degradation product of
Cav2.2. When Dom I-II was expressed alone it was
detected by anti-Cav2.2, but not anti-GFP Abs
(band at 120 kDa in Fig. 6b but not Fig. 6a, lane 2). However, when GFP-Cav2.2 was expressed
together with Dom I-II, no band at 250 kDa was observed with
either Ab (Fig. 6a,b, lane 3), although Dom
I-II was detected by the anti-Cav2.2 Ab, to a similar level as when it was expressed alone (Fig. 6b,
compare lanes 2 and 3). This is in agreement with the
confocal imaging data (Fig. 2). No smaller molecular weight (MW) bands
that might represent partially synthesized or degradation products of
GFP-Cav2.2 were observed when it was
cotransfected with Dom I-II, using either Ab (Fig. 6a,b,
lane 3). Neither the 250 and 120 kDa bands nor the 100 kDa
putative proteolytic product of GFP-Cav2.2 were
present in nontransfected cells (Fig. 6a,b, lane
4). Similar results were obtained when
GFP-Cav2.2 was expressed together with GFP-Dom
I-II or Dom I (results not shown). In contrast, in the case of
coexpression of GFP-Cav2.2 with Dom III-IV,
there was little, if any, reduction in the amount of
GFP-Cav2.2 (Fig. 6c, compare
lanes 1 and 3), in agreement with the confocal imaging data
(Fig. 2g).

View larger version (86K):
[in this window]
[in a new window]
|
Figure 6.
Effect of cotransfection of COS-7 cells with Dom
I-II on the level of expressed full-length GFP-Cav2.2.
Western blotting and immunodetection using (a, c)
anti-GFP Ab (lanes 1-4), or anti-rabbit brain
1B II-III loop Ab (b, lanes
1-4), performed as described in Materials and Methods.
a, b, Lane 1,
GFP-Cav2.2; lane 2, Dom I-II; lane
3, GFP-Cav2.2 and Dom I-II, and lane
4, no transfected cDNA. Positions of molecular weight markers
are shown on the left referring to both a and
b. Closed arrow shows position of
Cav2.2 band, detected with both Abs, and open
arrow shows position of Dom I-II, only detected with
anti-II-III loop Ab. Representative of four similar experiments.
c, Lane 1: GFP-Cav2.2; lane
2, Dom III-IV; lane 3, GFP-Cav2.2
and Dom III-IV, and lane 4, no transfected cDNA.
Positions of molecular weight markers are shown on the
left. Closed arrow shows position of
Cav2.2 band.
|
|
 |
DISCUSSION |
It has been suggested that four-domain
Na+ and Ca2+
channels arose during evolution from two sequential gene duplications
of a K+ channel (Plummer et al., 1997 ) and
that expression of the two-domain isoforms still occurs in a
developmentally regulated manner (Plummer et al., 1997 ). It is possible
that the two-domain isoforms of Cav1.1,
Cav1.2, and the Na+
channel SCN8A may all serve a similar function (Plummer et al., 1997 ).
It would be predicted from our results that this would be a
dominant-negative function, to suppress expression of the full-length
channel. In support of this, a three-domain construct of an ascidian
calcium channel, thought to be expressed from maternal transcript, has
recently been shown to suppress expression of the full-length ascidian
calcium channel (Okagaki et al., 2001 ).
Dominant-negative suppression of K+
channel tetramer function by transmembrane fragments has been studied
previously for the Kv channel family
(Tu et al., 1995 ). This suppression effect was found to involve
multiple transmembrane peptides but not to affect synthesis (Tu et al.,
1996 ). As discussed in that study, the formation of
K+ channel tetramers will involve multiple
interactions between domains, and disruption at any stage of biogenesis
may be sufficient to cause suppression of functional expression (Tu et
al., 1996 ). In contrast, another recent study showed the existence of a
pathway involving arrest of synthesis and rapid degradation of
mis-folded human ether-a-go-go-related gene (HERG)
K+ channel tetramers induced by a point
mutation (Kagan et al., 2000 ).
Here we have examined whether the mechanism of suppression of
expression of full-length Cav2.2 by truncated
constructs involves (1) interference with gating of the channel
inserted in the plasma membrane, (2) interference with delivery to the
plasma membrane, (3) increased protein degradation, or (4) synthesis
arrest. Below we consider these possibilities in turn.
Is there an impairment of gating caused by association of channel
fragments with full-length Cav2.2 in the plasma
membrane? From the electrophysiological data, GFP-Dom I-II coexpressed
with Dom III-IV resulted in small but reproducible whole-cell calcium channel currents and produced single channels whose properties, apart
from frequency of observation, were indistinguishable from wild type.
Therefore, at least a small proportion of the truncated constructs must
be able to fold and assemble together correctly with the normal
topology. Similar results have recently been obtained for coexpression
of two domain constructs of Cav1.1 (Ahern et al.,
2001 ).
Concerning the mechanism of suppression, a combination of the
whole-cell and single channel analysis indicates that the inhibition of
full-length Cav2.2 currents by Dom I-II is
attributable to a reduction in the number of channels, because there is
no alteration in any of their biophysical properties examined. Although
fewer Cav2.2 channels reach the plasma membrane,
their gating is not modified by an association with the truncated
construct. The apparent discrepancy between the confocal imaging data,
where almost no GFP fluorescence was seen when Dom I-II was
coexpressed with GFP-Cav2.2, and the
electrophysiological data, may be a function of the detection limit,
which has been calculated to be ~10,000 GFP molecules per tissue
culture cell (Patterson et al., 1997 ). From our data, only ~3000
channels would be required to give rise to the currents observed when
Dom I-II is coexpressed with GFP-Cav2.2. It is
also possible that the GFP tag is synthesized, but mis-folded, and therefore not fluorescent, but it was also not recognized by the GFP Ab.
Is there interference in the delivery of the channel to the plasma
membrane? Cav subunits are involved both in
trafficking 1 subunits and in modulating their biophysical
properties (Chien et al., 1995 ; Brice et al., 1997 ; Bichet et al.,
2000 ; Canti et al., 2001 ). It is conceivable that trafficking of
Cav2.2 through the endoplasmic reticulum might be
compromised by scavenging of Cav subunits by
the truncated fragments. However, suppression was not prevented by
expression of an increased amount of subunit. Furthermore, the
properties of the currents in the presence of the truncated constructs
did not mimic those of Cav2.2 expressed without
subunits in COS-7 cells or Xenopus oocytes, where both the V50 for activation and
steady-state inactivation were markedly depolarized (Canti et al.,
2000 ; Meir et al., 2000 ; Stephens et al., 2000 ). Moreover, suppression
of GFP-Cav2.2 protein expression remained
evident in the absence of coexpressed accessory subunits, indicating that it occurs before trafficking out of the endoplasmic reticulum [for which Cav is required (Bichet
et al., 2000 )]. From yeast two-hybrid experiments we found that, of
the intracellular I-II loop, the N terminus and the C terminus of
Cav2.2, only the I-II loop represents a
high-affinity interaction site for 1b. However, coexpression of the
I-II loop with Cav2.2 did not reduce Cav2.2 IBa,
again indicating that scavenging of subunits is not responsible for
the suppressive effect of Dom I and Dom I-II. The lack of effect of
the I-II loop, either to reduce expression or to affect the
V50 for activation is presumably
because the subunit is present in excess, as also demonstrated in
our recent study in Xenopus oocytes, where the maximum
effect of 3 on expression occurred at ~6 pg of 3 cDNA for 540 pg of Cav2.2 cDNA injected per oocyte (Canti et
al., 2001 ).
Another potential mechanism of suppression would be prevention of
correct folding of Cav2.2 by the truncated
domains, so that endoplasmic reticulum retention signals are not
masked, and the mis-folded channel is retained in the endoplasmic
reticulum. Although this may be the mechanism of
Cav2.2 suppression by the Dom III-IV construct,
where loss of Cav2.2 protein was not observed
(Figs. 2g, 6c), in the case of the truncated
constructs containing domain I, instead of observing an accumulation of
the GFP-Cav2.2 signal in the endoplasmic
reticulum, we observed an almost complete loss of
GFP-Cav2.2 fluorescence (Figs. 2b,d,
5a,b).
This points to decreased synthesis or stability of the
Cav2.2 protein. In experiments to distinguish
between these possibilities, we found that inhibition of proteasome
activity by lactacystin did not increase the amount of
GFP-Cav2.2 observed in the presence of Dom
I-II, suggesting that the mechanism does not involve enhanced proteolysis, in contrast to the finding with the HERG
K+ channel mutant (Kagan et al., 2000 ).
From these results, the most likely explanation for suppression by
truncated constructs containing domain I is that synthesis of
full-length Cav2.2 is arrested. Furthermore, the
intracellular N terminus alone was ineffective, suggesting that
suppression may occur by interaction of the nascent transmembrane
segments of the first domain of Cav2.2 with Dom I
of the truncated construct. Synthesis of polytopic proteins passes
through a state where up to six nascent transmembrane -helices span
the endoplasmic reticulum membrane, but are not yet integrated in its
lipid bilayer, associating via ionic rather than hydrophobic
interactions (Borel and Simon, 1996 ). When the initial transmembrane
-helices of Cav2.2 are in this state, it may
be that interference occurs with further synthesis of the full-length
channel, because of interaction with the Dom I and Dom I-II proteins,
where, in the absence of all four transmembrane domains for assembly,
inappropriate residues would remain exposed. It is possible that this
would effectively halt polysomal movement on each
Cav2.2 mRNA. The lack of effect of the Dom
III-IV construct to suppress synthesis of Cav2.2
could be attributed to the fact that synthesis and assembly of
Cav2.2 is nearer completion before the
interaction occurs with transmembrane segments of Dom III-IV, which
then results in trapping in the endoplasmic reticulum. Furthermore, the
fact that there is a reduction, rather than an increase, in suppression
when Dom I-II and Dom III-IV are together coexpressed with
Cav2.2, also points to the exposure of
inappropriate residues on the singly expressed hemichannels as a
mechanism of suppression.
In agreement with the hypothesis that synthesis of
Cav2.2 is suppressed, we observed loss of
full-length GFP-Cav2.2 protein, when it was
coexpressed with either Dom I-II or Dom I. Furthermore, no smaller MW
partially synthesized or degradation products of Cav2.2 were observed. This also points to
synthesis arrest at an early stage, rather than enhanced degradation.
However, although attenuation of translation is a well established
aspect of the unfolded protein response that occurs when there is an
accumulation of mis-folded proteins in the endoplasmic reticulum
(Chevet et al., 2001 ), in the present case the synthesis inhibition was
specific to Cav2.2, because coexpression of
Cav2.2 did not appear to reduce the level of Dom
I-II, and this may therefore be a novel mechanism. We are currently
examining whether the Cav2.2 mRNA level is
reduced, and if so, whether this is a primary event, or a consequence
of synthesis inhibition.
In conclusion, it is likely that early in the process of synthesis, if
Cav2.2 associates with domain I of the truncated
constructs in the endoplasmic reticulum membrane, translation of the
full-length Cav2.2 channel is largely prevented.
This finding may generalize to all normally or pathologically occurring
calcium channel splice variants that form such truncated proteins and
represent a physiological mechanism for developmental or
tissue-specific channel expression.
 |
FOOTNOTES |
Received June 11, 2001; revised Aug. 15, 2001; accepted Aug. 23, 2001.
This work was supported by the Wellcome Trust and Medical Research
Council (MRC). A.R. was an MRC PhD student. We thank Dr. E. Perez-Reyes
for 1b cDNA, Dr. Y. Mori for Cav2.2 cDNA, Dr. H. Chin
for 2 -1 cDNA, and Dr. T Hughes for mut3-GFP cDNA. We thank Nuria
Balaguero, Wendy Pratt, and Manuela Nieto-Rostro for technical assistance.
A.R. and F.B. contributed equally to this work.
Correspondence should be addressed to A. C. Dolphin, Department of
Pharmacology, University College London, Gower Street, London WC1E6BT,
UK. E-mail: a.dolphin{at}ucl.ac.uk.
 |
REFERENCES |
-
Ahern CA,
Arikkath J,
Vallejo P,
Gurnett CA,
Powers PA,
Campbell KP,
Coronado R
(2001)
Intramembrane charge movements and excitation-contraction coupling expressed by two-domain fragments of the Ca2+ channel.
Proc Natl Acad Sci USA
98:6935-6940[Abstract/Free Full Text].
-
Bell DC,
Butcher AJ,
Berrow NS,
Page KM,
Brust PF,
Nesterova A,
Stauderman KA,
Seabrook GR,
Nurnberg B,
Dolphin AC
(2001)
Biophysical properties, pharmacology and modulation of human, neuronal L-type (
1D, Cav1.3) voltage-dependent calcium currents.
J Neurophysiol
85:816-828[Abstract/Free Full Text]. -
Bichet D,
Cornet V,
Geib S,
Carlier E,
Volsen S,
Hoshi T,
Mori Y,
De Waard M
(2000)
The I-II loop of the Ca2+ channel
1 subunit contains an endoplasmic reticulum retention signal antagonized by the subunit.
Neuron
25:177-190[ISI][Medline]. -
Birnbaumer L,
Campbell KP,
Catterall WA,
Harpold MM,
Hofmann F,
Horne WA,
Mori Y,
Schwartz A,
Snutch TP,
Tanabe T,
Tsien RW
(1994)
The naming of voltage-gated calcium channels.
Neuron
13:505-506[ISI][Medline].
-
Borel AC,
Simon SM
(1996)
Biogenesis of polytopic membrane proteins: membrane segments assemble within translocation channels prior to membrane integration.
Cell
85:379-389[ISI][Medline].
-
Brice NL,
Berrow NS,
Campbell V,
Page KM,
Brickley K,
Tedder I,
Dolphin AC
(1997)
Importance of the different
subunits in the membrane expression of the 1A and 2 calcium channel subunits: studies using a depolarisation-sensitive 1A antibody.
Eur J Neurosci
9:749-759[ISI][Medline]. -
Campbell V,
Berrow N,
Brickley K,
Page K,
Wade R,
Dolphin AC
(1995)
Voltage-dependent calcium channel
-subunits in combination with alpha1 subunits have a GTPase activating effect to promote hydrolysis of GTP by G alphao in rat frontal cortex.
FEBS Lett
370:135-140[ISI][Medline]. -
Canti C,
Bogdanov Y,
Dolphin AC
(2000)
Interaction between G proteins and accessory
subunits in the regulation of 1B calcium channels in Xenopus oocytes.
J Physiol (Lond)
527:419-432[Abstract/Free Full Text]. -
Canti C,
Davies A,
Berrow NS,
Butcher AJ,
Page KM,
Dolphin AC
(2001)
Evidence for two concentration-dependent processes for
subunit effects on 1B calcium channels.
Biophys J
81:1439-1451[Abstract/Free Full Text]. -
Catterall WA
(2000)
Structure and regulation of voltage-gated Ca2+ channels.
Annu Rev Cell Dev Biol
16:521-555[ISI][Medline].
-
Chevet E,
Cameron PH,
Pelletier MF,
Thomas DY,
Bergeron JJM
(2001)
The endoplasmic reticulum: integration of protein folding, quality control, signaling and degradation.
Curr Opin Struct Biol
11:120-124[ISI][Medline].
-
Chien AJ,
Zhao XL,
Shirokov RE,
Puri TS,
Chang CF,
Sun D,
Rios E,
Hosey MM
(1995)
Roles of a membrane-localized
subunit in the formation and targeting of functional L-type Ca2+ channels.
J Biol Chem
270:30036-30044[Abstract/Free Full Text]. -
Cormack BP,
Valdivia RH,
Falkow S
(1996)
FACS-optimized mutants of the green fluorescent protein (GFP).
Gene
173:33-38[ISI][Medline].
-
Denier C,
Ducros A,
Vahedi K,
Joutel A,
Thierry P,
Ritz A,
Castelnovo G,
Deonna T,
Gerard P,
Devoize JL,
Gayou A,
Perrouty B,
Soisson T,
Autret A,
Warter JM,
Vighetto A,
Van Bogaert P,
Alamowitch S,
Roullet E,
Tournier-Lasserve E
(1999)
High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2.
Neurology
52:1816-1821[Abstract/Free Full Text].
-
Ertel EA,
Campbell KP,
Harpold MM,
Hofmann F,
Mori Y,
Perez-Reyes E,
Schwartz A,
Snutch TP,
Tanabe T,
Birnbaumer L,
Tsien RW,
Catterall WA
(2000)
Nomenclature of voltage-gated calcium channels.
Neuron
25:533-535[ISI][Medline].
-
Kagan A,
Yu Z,
Fishman GI,
McDonald TV
(2000)
The dominant negative LQT2 mutation A561V reduces wild-type HERG expression.
J Biol Chem
275:11241-11248[Abstract/Free Full Text].
-
Malouf NN,
McMahon DK,
Hainsworth CN,
Kay BK
(1992)
A two-motif isoform of the major calcium channel subunit in skeletal muscle.
Neuron
8:899-906[Medline].
-
Meir A,
Dolphin AC
(1998)
Known calcium channel
1 subunits can form low threshold, small conductance channels, with similarities to native T type channels.
Neuron
20:341-351[ISI][Medline]. -
Meir A,
Bell DC,
Stephens GJ,
Page KM,
Dolphin AC
(2000)
Calcium channel
subunit promotes voltage-dependent modulation of 1B by G .
Biophys J
79:731-746[Abstract/Free Full Text]. -
Mittman S,
Agnew WS
(2000)
Three new alternative spliced exons of the calcium channel 1B subun
|